Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma
Abstract Oncolytic viruses (OVs) emerge as a promising cancer immunotherapy. However, the temporal impact on tumor cells and the tumor microenvironment, and the nature of anti-tumor immunity post-therapy remain largely unclear. Here we report that CD4+ T cells are required for durable tumor control...
Saved in:
Main Authors: | Jeffrey M. Grimes, Sadashib Ghosh, Shamza Manzoor, Li X. Li, Monica M. Moran, Jennifer C. Clements, Sherrie D. Alexander, James M. Markert, Jianmei W. Leavenworth |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-55455-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BCL6 (B-cell lymphoma 6) expression in adenomyosis, leiomyomas and normal myometrium.
by: Loreta Canivilo Salas, et al.
Published: (2025-01-01) -
Zika virus has an oncolytic activity against human glioblastoma U87 cells
by: V. A. Svyatchenko, et al.
Published: (2019-01-01) -
Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison
by: Tania Fiaschi, et al.
Published: (2012-01-01) -
Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP
by: Kaede Hiruma, et al.
Published: (2025-01-01) -
Sequential Release HydroLipo System for STING Gene Epigenetic Reprogramming and Immune Activation in Glioblastoma
by: Hao Yu, et al.
Published: (2025-02-01)